Patents by Inventor Samuel Evan Day

Samuel Evan Day has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 13C-MR imaging or spectroscopy of cell death
    Patent number: 8951500
    Abstract: The invention relates to method of 13C-MR imaging and/or 13C-MR spectroscopy of cell death using an imaging medium which comprises hyperpolarized 13C-pyruvate.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: February 10, 2015
    Assignee: GE Healthcare AS
    Inventors: Kevin M. Brindle, Samuel Evan Day, Mikko Iivari Kettunen
  • 13C-MR IMAGING OR SPECTROSCOPY OF CELL DEATH
    Publication number: 20100226859
    Abstract: The invention relates to method of 13C-MR imaging and/or 13C-MR spectroscopy of cell death using an imaging medium which comprises hyperpolarised 13C-pyruvate.
    Type: Application
    Filed: August 17, 2007
    Publication date: September 9, 2010
    Inventors: Kevin M. Brindle, Samuel Evan Day, Mikko Iivari Kettunen
  • IMAGING MEDIUM COMPRISING LACTATE AND HYPERPOLARISED 13C-PYRUVATE
    Publication number: 20100178249
    Abstract: The invention relates to an imaging medium containing lactate and hyperpolarised 13C-pyruvate, a method to produce said imaging medium, use of said imaging medium and methods of 13C-MR imaging and/or 13C-MR spectroscopy wherein said imaging medium is used.
    Type: Application
    Filed: August 17, 2007
    Publication date: July 15, 2010
    Inventors: Kevin M. Brindle, Samuel Evan Day